You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent mycosis fungoides/Sezary syndrome

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
Feb 1, 2021

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

Withdrawn
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Zürich, Switzerland
    UniversitaetsSpital Zurich - Division of Dermatology
Aug 31, 2021

Lymphoma Trial in Stanford, Chicago, Houston (lenalidomide)

Completed
Has Results
  • Lymphoma
  • Stanford, California
  • +2 more
Nov 13, 2020

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

Completed
  • Cutaneous T Cell Lymphoma
  • +2 more
  • Leeds, United Kingdom
    Covance Clinical research Unit Ltd.
Feb 3, 2022

Poteligeo in Adult Patients With MF and SS (PROSPER)

Not yet recruiting
  • Mycosis Fungoides and Sézary Syndrome
  • Saint Louis, Missouri
  • +15 more
Jul 8, 2022

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

Active, not recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

Terminated
Has Results
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
  • +13 more
  • Chicago, Illinois
    Northwestern University
Jul 24, 2019

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Recurrent Mycosis Fungoides and Sezary Syndrome, Refractory Mycosis Fungoides and Sezary Syndrome, Stage IB Mycosis Fungoides

    Completed
    Has Results
    • Recurrent Mycosis Fungoides and Sezary Syndrome
    • +8 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Palo Alto, California
    • +7 more
    Aug 29, 2019

    Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

    Active, not recruiting
    • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
    • +18 more
    • Anti-ICOS Monoclonal Antibody MEDI-570
    • +2 more
    • Duarte, California
    • +22 more
    Jan 18, 2023

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

    Recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +9 more
    • Anti-CD30/CD16A Monoclonal Antibody AFM13
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma

    Recruiting
    • Anaplastic Large Cell Lymphoma
    • +19 more
    • Duarte, California
    • +2 more
    Aug 15, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous

    Recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 6, 2022

    Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

    Recruiting
    • Myelodysplastic Syndrome
    • +16 more
    • Computed Tomography
    • +6 more
    • Scottsdale, Arizona
    • +2 more
    Feb 3, 2022

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +99 more
    • alemtuzumab
    • +6 more
    • Denver, Colorado
    • +6 more
    Jan 15, 2020

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

    Recruiting
    • Brain and Central Nervous System Tumors
    • +8 more
    • 3'-deoxy-3'-[18F]fluorothymidine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 30, 2022

    T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

    Active, not recruiting
    • T-Cell Lymphoma
    • +4 more
    • LB1901
    • Rochester, Minnesota
    • +3 more
    Feb 15, 2022

    Cutaneous T-Cell Lymphomas Trial in Dallas (TSEBT, TSEBT and pembrolizumab)

    Withdrawn
    • Cutaneous T-Cell Lymphomas
    • TSEBT
    • TSEBT and pembrolizumab
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Apr 20, 2020

    Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

    Completed
    Has Results
    • Mycosis Fungoides
    • Sezary Syndrome
    • A matched peripheral donor stem cells
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 2, 2020

    Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

    Recruiting
    • Lymphoma, T-cell, Peripheral
    • Lymphoma, T-cell, Cutaneous
    • Nagoya, Japan
    • +2 more
    Nov 24, 2022